Genomic Health, Inc. | TalkMarkets

Latest Posts

Exact Sciences Is Going Higher

Article By: Quad 7 Capital

Tuesday, July 30, 2019 12:23 PM EDT

With the merger of Exact Sciences and Genomic Health, investors should be looking for EXAS earnings positive results by the end of 2020. In the meantime, revenue growth continues to be astounding.

In this article: EXAS, GHDX Also: PFE

Read

Triple Play Acquiring Triple Play

Article By: Bespoke Investment Group

Monday, July 29, 2019 1:14 PM EDT

Exact Sciences announced plans today to acquire another health care company, Genomic Health. The two announced that the agreement would combine Exact Sciences with Genomic Health for $72 per share in cash and stock.

In this article: GHDX, EXAS

Read

Exact Sciences Will Acquire Genomic Health In $2.8B Deal

Article By: Benzinga

Monday, July 29, 2019 9:37 AM EDT

Exact Sciences Corp. will acquire Genomic Health, Inc. for $72 per share in a cash and stock transaction valued at $2.8 billion.

In this article: GHDX, EXAS

Read

4 Small Biotech Stocks Likely To Witness More Upside In 2019

Article By: Zacks Investment Research

Saturday, March 30, 2019 5:45 AM EDT

Here are four companies from the biotech/drug sector which have performed well so far in 2019 and still hold upside. All these stocks have seen their share price and earnings estimates rise this year.

In this article: ANIP, KMDA, GHDX, NLNK Also: VRTX, BIIB, AMGN

Read